HighMark Wealth Management »

X4 Pharmaceuticals shares owned by HighMark Wealth Management

Quarter-by-quarter ownership of X4 Pharmaceuticals (XFOR) shares owned by HighMark Wealth Management from 13F filings

Historical chart of HighMark Wealth Management investment in X4 Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including X4 Pharmaceuticals held by HighMark Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in X4 Pharmaceuticals by HighMark Wealth Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $120 180 0.67
2024-06-30 $104 180 0.58

More positions owned by HighMark Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Core S&p Us Vlu (IUSV)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Smlc (DWAS)
Ishares Tr Core S&p Mcp Etf (IJH)
Wells Fargo & Company (WFC)
Paragon 28 (FNA)
Performant Finl (PFMT)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
NVIDIA Corporation (NVDA)
Eli Lilly & Co. (LLY)
AtriCure (ATRC)
Apple (AAPL)

View all positions for HighMark Wealth Management

Top funds holding X4 Pharmaceuticals

Bain Capital Life Sciences Investors
NEA Management Company
BlackRock
BlackRock
Vanguard Group
OrbiMed Advisors
Kingdon Capital Management
Soleus Capital Management
Perceptive Advisors
Geode Capital Management
State Street Corporation
Ensign Peak Advisors
Sio Capital Management
Schonfeld Strategic Advisors
Pale Fire Capital SE

View all funds holding X4 Pharmaceuticals